Mayne Pharma Group (ASX:MYX) Days Payable : 287.17 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Mayne Pharma Group Days Payable?

Mayne Pharma Group's average Accounts Payable for the six months ended in Dec. 2023 was A$129.3 Mil. Mayne Pharma Group's Cost of Goods Sold for the six months ended in Dec. 2023 was A$82.1 Mil. Hence, Mayne Pharma Group's Days Payable for the six months ended in Dec. 2023 was 287.17.

The historical rank and industry rank for Mayne Pharma Group's Days Payable or its related term are showing as below:

ASX:MYX' s Days Payable Range Over the Past 10 Years
Min: 37.36 Med: 91.59 Max: 682.77
Current: 682.77

During the past 13 years, Mayne Pharma Group's highest Days Payable was 682.77. The lowest was 37.36. And the median was 91.59.

ASX:MYX's Days Payable is ranked better than
95.19% of 977 companies
in the Drug Manufacturers industry
Industry Median: 86.82 vs ASX:MYX: 682.77

Mayne Pharma Group's Days Payable declined from Dec. 2022 (297.74) to Dec. 2023 (287.17). It may suggest that Mayne Pharma Group accelerated paying its suppliers.

Mayne Pharma Group Days Payable Historical Data

The historical data trend for Mayne Pharma Group's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mayne Pharma Group Days Payable Chart

Mayne Pharma Group Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Payable

Get a 7-Day Free Trial

93.74

63.30

64.10

76.18

174.29

Mayne Pharma Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															147.52	120.96	297.74	3,646.71	287.17

Competitive Comparison of Mayne Pharma Group's Days Payable

For the Drug Manufacturers - General subindustry, Mayne Pharma Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mayne Pharma Group's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mayne Pharma Group's Days Payable distribution charts can be found below:

* The bar in red indicates where Mayne Pharma Group's Days Payable falls into.

Mayne Pharma Group Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Mayne Pharma Group's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

	Days Payable (A: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2022 )	+	Accounts Payable (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (63.571	+	32.027)	/	2 )	/	100.099	*	365
=	47.799					/	100.099	*	365
=	174.29

Mayne Pharma Group's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (32.027	+	226.486)	/	2 )	/	82.143	*	365 / 2
=	129.2565					/	82.143	*	365 / 2
=	287.17

Mayne Pharma Group Days Payable Related Terms

Thank you for viewing the detailed overview of Mayne Pharma Group's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Mayne Pharma Group (ASX:MYX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mayne Pharma Group Ltd (ASX:MYX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

MAYNF:USA HG6:Germany

Address

1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106

Website

http://www.maynepharma.com

Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Branded Products (BPD) and Portfolio Products Division (PPD). The Portfolio Products Division distributes dermatology products (branded and generic) in the US on a portfolio basis, The Branded Products Division distributes branded women's health products in the US. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.